Evidence map›Paper›PMID 42597987›Full record

ArticleJournal of smoking cessation2020

Persistence targeted smoking cessation for smokers with schizophrenia or schizoaffective disorder: a feasibility study.

Marc L Steinberg, Benjamin Billingsley, Rachel Rosen, Elizabeth E Epstein, Shou-En Lu, Nicole Weickert, Jill M Williams

Abstract read
In one paragraph

Article in Journal of smoking cessation, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Trial
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Marc L SteinbergDepartment of Psychiatry, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ 08901, USA.ORCID 0000-0001-8180-8682
Benjamin BillingsleyDepartment of Psychology, Rutgers, The State University of New Jersey, New Brunswick, NJ 08901, USA.
Rachel RosenDepartment of Psychology, Rutgers, The State University of New Jersey, New Brunswick, NJ 08901, USA.
Elizabeth E EpsteinDepartment of Psychiatry, University of Massachusetts Medical School, Worcester, MA 01605, USA.
Shou-En LuRutgers School of Public Health, Piscataway, NJ 08854, USA.
Nicole WeickertDepartment of Psychology, Rutgers, The State University of New Jersey, New Brunswick, NJ 08901, USA.
Jill M WilliamsDepartment of Psychiatry, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ 08901, USA.

Funding

Persistence Targeted Smoking Cessation in Schizophrenia (PTSC-S)R21DA041163 · NIDA · RBHS-ROBERT WOOD JOHNSON MEDICAL SCHOOL · PI STEINBERG, MARC L · 2016 to 2017
$411k
NIDA NIH HHS R21 DA041163
6 · The paper itself

Abstract

Introduction: Individuals with schizophrenia are more likely to smoke and less likely to quit smoking than those without schizophrenia. Because task persistence is lower in smokers with than without schizophrenia, it is possible that lower levels of task persistence may contribute to greater difficulties in quitting smoking observed among smokers with schizophrenia. Aims: To develop a feasible and acceptable intervention for smokers with schizophrenia. Methods: Participants ( Results: In total, 93.8% of participants rated the intervention as at least a 6 out of 7 regarding how 'easy to understand' it was and 81.3% rated the treatment as at least a 6 out of 7 regarding how helpful it was to them. A total of 62.5% attended at least six of the eight sessions and session attendance was positively related to nicotine dependence and age and negatively related to self-efficacy for quitting. Discussion: This intervention was feasible and acceptable to smokers with schizophrenia. Future research will examine questions appropriate for later stages of therapy development such as initial efficacy of the intervention and task persistence as a mediator of treatment outcome.

Indexed as

Cessationdistress tolerancepersistenceschizophreniatherapytobacco

Identifiers

PMID42597987
PMCPMC13470118

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.